Dyne Therapeutics Inc (DYN)
28.64
-0.14
(-0.49%)
USD |
NASDAQ |
Nov 05, 11:42
Dyne Therapeutics 1 Year Total Returns (Daily): 249.7% for Nov. 4, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
November 04, 2024 | 249.7% |
November 01, 2024 | 293.7% |
October 31, 2024 | 309.4% |
October 30, 2024 | 298.9% |
October 29, 2024 | 356.5% |
October 28, 2024 | 365.0% |
October 25, 2024 | 361.4% |
October 24, 2024 | 346.8% |
October 23, 2024 | 385.9% |
October 22, 2024 | 360.6% |
October 21, 2024 | 361.8% |
October 18, 2024 | 376.2% |
October 17, 2024 | 349.9% |
October 16, 2024 | 350.4% |
October 15, 2024 | 311.6% |
October 14, 2024 | 308.2% |
October 11, 2024 | 301.8% |
October 10, 2024 | 262.2% |
October 09, 2024 | 257.0% |
October 08, 2024 | 252.1% |
October 07, 2024 | 236.7% |
October 04, 2024 | 292.1% |
October 03, 2024 | 287.9% |
October 02, 2024 | 347.7% |
October 01, 2024 | 287.9% |
Date | Value |
---|---|
September 30, 2024 | 300.9% |
September 27, 2024 | 293.4% |
September 26, 2024 | 284.2% |
September 25, 2024 | 302.3% |
September 24, 2024 | 267.4% |
September 23, 2024 | 281.0% |
September 20, 2024 | 292.6% |
September 19, 2024 | 269.3% |
September 18, 2024 | 248.6% |
September 17, 2024 | 273.7% |
September 16, 2024 | 271.5% |
September 13, 2024 | 267.6% |
September 12, 2024 | 234.0% |
September 11, 2024 | 191.6% |
September 10, 2024 | 195.4% |
September 09, 2024 | 195.7% |
September 06, 2024 | 180.6% |
September 05, 2024 | 188.6% |
September 04, 2024 | 186.8% |
September 03, 2024 | 171.4% |
August 30, 2024 | 287.6% |
August 29, 2024 | 284.5% |
August 28, 2024 | 288.0% |
August 27, 2024 | 270.3% |
August 26, 2024 | 277.5% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-77.11%
Minimum
Jun 02 2022
385.9%
Maximum
Oct 23 2024
43.96%
Average
-4.52%
Median
1 Year Total Returns (Daily) Benchmarks
Sarepta Therapeutics Inc | 57.76% |
Capricor Therapeutics Inc | 547.4% |
Regenxbio Inc | -42.86% |
Catalyst Pharmaceuticals Inc | 65.20% |
Vertex Pharmaceuticals Inc | 25.81% |